Literature DB >> 10368816

Population-attributable risk for colon cancer in Italy.

C La Vecchia1, C Braga, S Franceschi, L Dal Maso, E Negri.   

Abstract

Risk factors for colon cancer have essentially been considered in terms of relative risks. From a public health viewpoint, however, their impact depends not only on the strength of the association, but also on the distribution of exposures in the population. Thus we used data from a case-control study conducted in Italy between 1992 and 1996 to estimate the population-attributable risks (PARs) for colon cancer in relation to educational level, physical activity, energy and vegetable intake, eating frequency, and family history of colorectal cancer. Cases were 1,225 incident, histologically confirmed colon cancer patients admitted to the major teaching and general hospitals in six Italian areas; controls were 4,154 subjects with no history of cancer, admitted to hospitals in the same catchment areas for acute, nonneoplastic diseases. By use of the distribution of the risk factors in the cases and the multivariate relative risk estimates, PARs were computed, i.e., the proportion of colon cancer that would have been avoided if all subjects were moved to the lowest exposure level. The PARs were 12% for high education, 14% for low physical activity, 14% for high energy intake, 22% for low vegetable intake, 7% for high eating frequency, and 8% for a family history of colorectal cancer. These factors together accounted for 56% of colon cancer cases. PARs were similar across age strata. Men had higher PARs for education, physical activity, and their combination, but lower PARs for energy, eating frequency, vegetable intake, and their combination than women. The percentage of colon cancers attributable to all factors considered together was 50% in men and 67% in women. Even if the PAR estimates were based on several arbitrary assumptions on the exposure distribution for various risk factors, available knowledge could, in principle, explain > 50% of cases in this Italian population, thus indicating and quantifying the theoretical scope for prevention.

Entities:  

Mesh:

Year:  1999        PMID: 10368816     DOI: 10.1207/S15327914NC330212

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  7 in total

1.  Meta-analysis: eating frequency and risk of colorectal cancer.

Authors:  Yanqiong Liu; Weizhong Tang; Limin Zhai; Shi Yang; Junrong Wu; Li Xie; Jian Wang; Yan Deng; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2013-12-05

2.  Proportion of colon cancer attributable to lifestyle in a cohort of US women.

Authors:  Jennifer Erdrich; Xuehong Zhang; Edward Giovannucci; Walter Willett
Journal:  Cancer Causes Control       Date:  2015-06-20       Impact factor: 2.506

3.  TNM and Modified Dukes staging along with the demographic characteristics of patients with colorectal carcinoma.

Authors:  Ayşe Neslin Akkoca; Serdar Yanık; Zeynep Tuğba Ozdemir; Fatma Gökşin Cihan; Süleyman Sayar; Tarık Gandi Cincin; Akın Cam; Cahit Ozer
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 4.  Diet and prevention of colorectal cancer.

Authors:  C Ritenbaugh
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

Review 5.  Physical activity and colorectal cancer.

Authors:  Martha L Slattery
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

6.  Age- and sex-specific spatio-temporal patterns of colorectal cancer mortality in Spain (1975-2008).

Authors:  Jaione Etxeberria; María Dolores Ugarte; Tomás Goicoa; Ana F Militino
Journal:  Popul Health Metr       Date:  2014-07-10

7.  Unrestrained eating behavior and risk of digestive system cancers: a prospective cohort study.

Authors:  Yin Zhang; Mingyang Song; Andrew T Chan; Eva S Schernhammer; Brian M Wolpin; Meir J Stampfer; Jeffrey A Meyerhardt; Charles S Fuchs; Susan B Roberts; Walter C Willett; Frank B Hu; Edward L Giovannucci; Kimmie Ng
Journal:  Am J Clin Nutr       Date:  2021-11-08       Impact factor: 8.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.